Membranoproliferative Glomerulonephritis Types I, II, and III
1 clinical trials · Condition
◉ Watch Membranoproliferative Glomerulonephritis Types I, II, and III
| Record | Firm | Date |
|---|---|---|
| A Proof-of-Mechanism Study to Determine the Effect of Danicopan on C3 Levels in Participants With C3G or IC-MPGN (NCT03124368) | Alexion Pharmaceuticals, Inc. | 2017-08-09 |
Track Membranoproliferative Glomerulonephritis Types I, II, and III automatically
Every clearance here is in the API, with alerts when new ones post.